Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Hein

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Endocrine-Related Cancer|November 18, 2015
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancerDeborah J Thompson, Tracy A O'Mara, Dylan M Glubb, et al.
Nature Genetics|May 3, 2016
Five endometrial cancer risk loci identified through genome-wide association analysisTimothy Ht Cheng, Deborah J Thompson, Tracy A O'Mara, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcomeKristin L White, Robert A Vierkant, Zachary C Fogarty, et al.
Human Genetics|December 10, 2014
Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer riskLuis G Carvajal-Carmona, Tracy A O'Mara, Jodie N Painter, et al.
British Journal of Cancer|June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis ConsortiumFilipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
International Journal of Cancer|August 28, 2020
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancerPik-Fang Kho, Frederic Amant, Daniela Annibali, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2016
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer SurvivalLara E Sucheston-Campbell, Rikki Cannioto, Alyssa I Clay, et al.
Scientific Reports|December 2, 2015
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1Timothy H T Cheng, Deborah Thompson, Jodie Painter, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerMatthew S Block, Bridget Charbonneau, Robert A Vierkant, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Endocrine-Related Cancer|November 18, 2015
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancerDeborah J Thompson, Tracy A O'Mara, Dylan M Glubb, et al.
Nature Genetics|May 3, 2016
Five endometrial cancer risk loci identified through genome-wide association analysisTimothy Ht Cheng, Deborah J Thompson, Tracy A O'Mara, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcomeKristin L White, Robert A Vierkant, Zachary C Fogarty, et al.
Human Genetics|December 10, 2014
Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer riskLuis G Carvajal-Carmona, Tracy A O'Mara, Jodie N Painter, et al.
British Journal of Cancer|June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis ConsortiumFilipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
International Journal of Cancer|August 28, 2020
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancerPik-Fang Kho, Frederic Amant, Daniela Annibali, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2016
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer SurvivalLara E Sucheston-Campbell, Rikki Cannioto, Alyssa I Clay, et al.
Scientific Reports|December 2, 2015
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1Timothy H T Cheng, Deborah Thompson, Jodie Painter, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerMatthew S Block, Bridget Charbonneau, Robert A Vierkant, et al.
Pageof 17